Aims of CEED3

The CEED3 project aims to develop diagnostic tools which will allow clinicians to differentiate between subtypes of diabetes.This will allow more appropriate treatment for diabetic patients.

The diagnostic tools will be used to identify:

  • Patients with specific subgroups of monogenic diabetes
  • Non diabetic and diabetic individuals with initial pancreatic beta-cell dysfunction at high risk of rapidly deteriorating glycaemia
  • Diabetic patients at increased risk of vascular complications

For each of these three clinical areas the development of diagnostic tools will involve a clearly defined process:

  • DISCOVERY of potential biomarkers
  • VALIDATION within test and population-based data samples
  • DEVELOPMENT of clinical application
  • DISSEMINATION of information and application